MedTech Global Insights cover art

MedTech Global Insights

MedTech Global Insights

By: Ran Chen
Listen for free

About this listen

 What's next in the future of health? Welcome to MedTech Global Insights, the podcast dedicated to uncovering the most disruptive technologies and brilliant minds in the medical field. Whether you're an industry professional, investor, or simply curious, subscribe for your dose of cutting-edge information and expert commentary.Copyright 2026 Ran Chen Biological Sciences Economics Science
Episodes
  • USA AI MedTech: Pure Global on the FDA's Hidden Data Mandate

    USA AI MedTech: Pure Global on the FDA's Hidden Data Mandate
    Apr 1 2026
    The U.S. FDA has quietly dropped a bombshell on the AI medical device industry. A new draft guidance is set to redefine what "post-market surveillance" means for software, creating a complex and costly new reality for innovators. This episode dives into the critical shift from focusing on pre-market approval to the necessity of continuous, real-world performance monitoring. We explore the challenge through the lens of a startup with a newly cleared AI diagnostic tool. The celebration of market approval is short-lived as they now face the daunting and expensive task of tracking their algorithm's performance in real-time. This isn't just a compliance headache; it's a potential threat to their business model and a new barrier to innovation. Key Takeaways: - What exactly is "algorithmic drift" and why is the FDA suddenly so concerned about it? - How will the new post-market data collection rules impact the budgets and survival of MedTech startups? - Does this new regulatory stance give larger, established companies an unfair advantage? - What are the hidden data privacy risks involved in continuous AI performance monitoring? - How might this U.S. policy shift influence regulators in Europe and Asia in the coming year? - What proactive strategies can software medical device companies adopt right now to prepare? - Is your current technical documentation prepared for this new lifecycle approach to regulation? Contact us at info@pureglobal.com or visit https://pureglobal.com/ or visit https://pureglobal.ai/ for FREE AI tools and free medical device database.
    Show More Show Less
    2 mins
  • Pure Global: Malaysia's MedTech Handshake, ASEAN's New Shortcut

    Pure Global: Malaysia's MedTech Handshake, ASEAN's New Shortcut
    Mar 31 2026
    In this episode of MedTech Global Insights, we unpack the most significant regulatory shift in Southeast Asia this year. The costly and time-consuming process of seeking individual device approvals in each country is being replaced by a powerful new trend: regulatory reliance. We dive into the new pilot program between Malaysia and Thailand that is creating an expedited pathway for market access. Imagine your company just spent two years and a significant budget getting your device approved in one country. Now you face the same mountain in the neighboring market. What if there was a way to use your existing approval to cut the next timeline in half? This is the reality that new ASEAN reliance programs are creating, but navigating them requires insider knowledge. This week's insights: - What exactly is the new Malaysia-Thailand regulatory reliance pilot program? - How does this "shortcut" actually accelerate your market entry process? - Which specific device classes are most likely to benefit? - Is this a one-off deal or part of a larger strategic trend in Southeast Asia? - How can approvals from the US or EU be leveraged in this new framework? - What are the hidden risks or documentation requirements for using these pathways? - How does this fundamentally change the strategy for MedTech expansion into Asia? - Which country's approval now offers the best "gateway" to the broader ASEAN region? For a deeper conversation on building your global strategy, contact us at info@pureglobal.com or visit https://pureglobal.com/. You can also explore our FREE AI tools and medical device database at https://pureglobal.ai/.
    Show More Show Less
    2 mins
  • Pure Global: EU's MedTech Shortage & The New Supply Rules

    Pure Global: EU's MedTech Shortage & The New Supply Rules
    Mar 30 2026
    The European Union is taking decisive action to combat the critical shortage of medical devices, a problem that has plagued its healthcare systems since the rollout of MDR. This episode unpacks the European Commission's new proposal for a mandatory six-month notification period for discontinuing devices, and what it means for manufacturers. This isn't just another form to fill out. it's a fundamental shift in market responsibility that directly impacts product lifecycle management, supply chain forecasting, and your competitive position. We explore the strategic challenges and opportunities this new era of mandatory transparency creates for MedTech companies operating in the EU. A French manufacturer of a critical diagnostic assay decides to discontinue the product due to low margins and high MDR compliance costs. Their plan was to quietly phase it out within three months. Suddenly, they are faced with the new six-month mandatory notification rule, forcing them to continue production at a loss, manage difficult conversations with distributors, and alert competitors to their exit strategy far earlier than intended, creating a significant strategic dilemma. Key Takeaways: - What triggers the mandatory six-month shortage notification requirement in the EU? - How does this new rule change the financial calculation for discontinuing a legacy product? - What specific information must manufacturers now provide to competent authorities? - How can you turn supply chain transparency into a competitive advantage in the EU market? - What are the legal and commercial risks of failing to comply with this new proposal? - How should this rule affect your product portfolio and end-of-life strategies? - Does this new EU rule align with or diverge from supply notification rules in the US or other markets? Contact us at info@pureglobal.com or visit https://pureglobal.com/ or visit https://pureglobal.ai/ for FREE AI tools and free medical device database.
    Show More Show Less
    2 mins
No reviews yet